	2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
	2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	R 2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR	12M AR	12M AR	12M AR	12M PRESS	12M IR
Total Revenue	614	527	960	1,045	908	1,233	1,142	1,424	1,375	1,219	2,051	1,574	1,395	1,745	2,012	2,267
Cost of Operating Revenue	530	445	703	680	659	914	820	1,038	1,050	952	1,200	1,233	1,091	1,340	1,180	1,368
Gross Profit	84	82	257	365	249	319	322	385	325	267	851	341	304	405	833	899
Gross Margin	13.7	15.6	26.8	34.9	27.4	25.9	28.2	27.1	23.6	21.9	41.5	21.7	21.8	23.2	41.4	39.6
Total Operating Expenses	619	514	791	883	779	1,036	957	1,206	1,253	1,158	1,878	1,489	1,344	1,644	1,914	2,147
Operating Profit	-5	13	168	162	129	197	185	217	122	60	173	85	50	101	99	120
Operating Margin	-0.8	2.5	17.5	15.5	14.2	16.0	16.2	15.3	8.8	5.0	8.4	5.4	3.6	5.8	4.9	5.3
Financing Income/(Expense) - Net	-41	-49	-50	-27	-15	-4	4	-4	-21	-9	-29	-38	-39	-77	-79	-76
Profit before Taxes	-41	-33	47	139	131	204	186	219	101	55	142	51	5	19	54	81
Income Taxes	-11	-10	16	47	45	71	62	77	27	16	43	13	-2	1	7	12
Profit after Tax	-30	-23	30	92	86	133	123	143	88	42	104	38	6	19	48	69
PAT Margin	-4.9	-4.4	3.1	8.8	9.5	10.8	10.7	10.1	6.4	3.4	5.1	2.4	0.5	1.1	2.4	3.0
EPS - Basic - ex Extraordinary Items	-2.88	-2.12	2.76	8.41	7.88	12.18	10.67	11.72	6.15	3.43	8.30	3.03	0.51	1.47	3.80	5.45
EPS - Diluted - ex Extraordinary Items	-2.88	-2.12	2.76	8.41	7.88	12.18	10.67	11.72	6.15	3.43	8.30	3.03	0.51	1.47	3.80	5.45
EBIT	-5	13	168	162	129	197	185	217	122	60	173	85	50	101	99	120
EBITDA	11	30	193	184	155	226	197	239	149	91	220	138	111	170	168	189
EBITDA Margin	1.8	5.6	20.2	17.6	17.1	18.4	17.3	16.8	10.9	7.5	10.7	8.8	8.0	9.7	8.4	8.4

Balance Sheet

Abridged

Understanding Balance Sheet

Bodal Chemicals Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	C 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	C 2015 Mar 31	R 2016 Mar 31	R 2017 Mar 31	2018 Mar 31	C 2019 Mar 31	R 2020 Mar 31	R 2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	AR	PRESS
Total Current Assets	280	190	397	323	307	405	537	616	758	871	1,131	851	813	898	934
Long-Term Investments	0	1	1	2	2	17	14	6	3	28	-	0	0	0	68
Property Plant & Equipment - Net	279	265	176	192	191	230	455	631	645	803	871	1,146	1,368	1,350	1,294
Total Non-Current Assets	295	283	196	211	210	302	538	683	713	885	992	1,270	1,474	1,455	1,421
Total Assets	575	473	593	534	517	707	1,075	1,299	1,471	1,755	2,122	2,121	2,288	2,353	2,356
Total Current Liabilities	374	177	287	254	267	316	348	411	495	610	804	621	694	767	762
Long Term Debt	134	246	216	86	1	8	1	13	1	107	214	362	448	410	351
Total Non-Current Liabilities	142	246	216	99	16	26	29	58	38	159	266	422	511	481	437
Total Liabilities	516	423	503	353	283	342	377	468	533	769	1,070	1,043	1,206	1,248	1,198
Total Shareholders' Equity	58	50	90	181	234	363	697	829	931	981	1,056	1,078	1,082	1,105	1,158
Minority Interest	1	-	-	-	-	2	1	1	7	5	-3	-	-	-	-
Total Equity	59	50	90	181	234	364	698	830	938	986	1,052	1,078	1,082	1,105	1,158
Total Liabilities & Equity	575	473	593	534	517	707	1,075	1,299	1,471	1,755	2,122	2,121	2,288	2,353	2,356

Cash Flow

Abridged

Understanding Cash Flow Statement

Bodal Chemicals Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	R 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
	R 2012 Mar 31	R 2013 Mar 31	2014 Mar 31	2015 Mar 31	2016 Mar 31	R 2017 Mar 31	2018 Mar 31	2019 Mar 31	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M PRESS
Operating CF bef Changes in Working Cap	-32.10	-16.43	130.21	127.51	106.43	152.88	138.69	170.90	121.28	74.86	145.05	96.65	76.22	99.76	108.12
Working Capital - Increase/(Decrease)	-1.00	-8.54	-123.66	43.88	14.18	-55.30	-132.96	13.19	-124.14	-97.04	-176.13	154.12	83.92	-61.64	1.99
Net CF from Operating Activities	-33.10	-24.97	6.55	171.38	120.62	97.58	5.73	184.10	-2.86	-22.18	-31.07	250.77	160.14	38.11	110.10
Capital Expenditures - Net	18.71	3.29	17.88	35.35	24.15	53.06	225.64	147.96	51.52	175.84	156.33	318.83	233.21	44.55	-4.12
Net CF from Investing Activities	-18.72	-3.29	-17.84	-36.28	-24.14	-70.53	-260.18	-135.36	-87.03	-175.11	-182.24	-317.02	-271.77	-42.43	-1.34
Dividends Paid - Cash - Total	6.20	0.00	0.02	0.05	7.80	3.95	6.55	9.78	19.48	-	9.74	9.81	1.35	0.06	0.05
Stock - Issuance/(Retirement) - Net	1.36	15.50	9.50	-	-25.00	-	218.60	-	43.83	-	0.15	0.17	0.17	0.15	-
Debt - LT & ST - Issuance/(Retirement) - Total	49.85	11.59	2.35	-134.82	-64.41	-10.06	29.43	-30.35	74.52	194.74	220.29	83.39	136.41	7.54	-113.55
Net Cash Flow from Financing Activities	52.63	27.09	11.83	-134.87	-97.21	-14.01	241.48	-42.13	94.85	194.74	210.70	73.75	135.22	7.64	-113.60
Free Cash Flow to Equity	-1.96	-16.67	-8.98	1.21	32.06	34.46	-190.48	5.79	20.14	-3.29	32.89	15.33	63.34	1.11	0.68
Free Operating CF net dividend	-63.27	-28.78	-11.67	135.87	88.41	34.81	-229.28	26.08	-74.44	-200.31	-199.90	-96.79	-86.18	-8.40	74.29
Free Operating CF	-57.07	-28.78	-11.65	135.92	96.21	38.76	-222.72	35.86	-54.96	-200.31	-190.16	-86.98	-84.83	-8.34	74.34

Business Segment Analysis

FY End:

Mar 25

Bodal Chemicals Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Chemicals (100.0%)₹ 46.45 Cr

Revenue / Sales

Chemicals (100.0%)₹ 1,744.94 Cr

Assets

Chemicals (100.0%)₹ 2,352.90 Cr

Operating Income

Chemicals (100.0%)₹ 101.38 Cr

Regional Segment Analysis

FY End:

Mar 25

Bodal Chemicals Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

Domestic Operations (75.8%)₹ 1,323.06 CrExternal Operations (24.2%)₹ 421.87 Cr

Historical Segment Analysis

Track how Bodal Chemicals Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31
Chemicals	52	178	159	338	245	46

Frequently Asked Questions

What is the revenue of Bodal Chemicals Ltd.?

The latest trailing twelve month revenue of Bodal Chemicals Ltd. is ₹ 2,267.08 Cr, reflecting a 1-year growth of 27.57% and a 3-year CAGR of 16.12%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Bodal Chemicals Ltd.?

The latest trailing twelve month net profit (PAT) of Bodal Chemicals Ltd. is ₹ 68.67 Cr, with a 3-year earnings CAGR of 58.34%. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Bodal Chemicals Ltd.?

The trailing twelve month EBITDA of Bodal Chemicals Ltd. is approximately ₹ 119.87 Cr (based on an operating margin of 5.29%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Bodal Chemicals Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Bodal Chemicals Ltd. is 5.45. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Bodal Chemicals Ltd.?

The debt-to-equity ratio of Bodal Chemicals Ltd. stands at 0.70. The interest coverage ratio is 1.58x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Bodal Chemicals Ltd.?

The estimated book value per share of Bodal Chemicals Ltd. is 91.91 (derived from a P/B ratio of 0.95 and market price of ₹ 87.05), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Bodal Chemicals Ltd.?

The trailing twelve month operating cash flow of Bodal Chemicals Ltd. is ₹ 110.10 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Bodal Chemicals Ltd. report consolidated or standalone financials?

Bodal Chemicals Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.